ancremonam

N/A

Report date: 2022/07/19 20:00:45

Base Information

Drug Nameancremonam
Drug Alias NameLYS-228
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsUrinary Tract InfectionsIntraabdominal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmarkGreece
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgBoston Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsUrinary Tract InfectionsIntraabdominal Infections

Other Information

ATC CodeN/A
Related LinksN/A